These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23818773)

  • 1. Polypharmacy in the HIV-infected older adult population.
    Gleason LJ; Luque AE; Shah K
    Clin Interv Aging; 2013; 8():749-63. PubMed ID: 23818773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV in older adults.
    Simone MJ; Appelbaum J
    Geriatrics; 2008 Dec; 63(12):6-12. PubMed ID: 19061274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.
    Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT;
    J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy among HIV infected people aged 50 years or older.
    Fernández Cañabate S; Ortega Valín L
    Colomb Med (Cali); 2019 Sep; 50(3):142-152. PubMed ID: 32284660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection.
    Greene M; Steinman MA; McNicholl IR; Valcour V
    J Am Geriatr Soc; 2014 Mar; 62(3):447-53. PubMed ID: 24576251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
    Smith JM; Flexner C
    AIDS; 2017 Jun; 31 Suppl 2():S173-S184. PubMed ID: 28471948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human immunodeficiency virus infection in the elderly].
    Bogner JR
    Z Gerontol Geriatr; 2020 Mar; 53(2):179-191. PubMed ID: 31832770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
    Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
    Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.
    Cantudo-Cuenca MR; Jiménez-Galán R; Almeida-Gonzalez CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2014 Aug; 20(8):844-50. PubMed ID: 25062078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of HIV treatment in an era of polypharmacy.
    Back D; Marzolini C
    J Int AIDS Soc; 2020 Feb; 23(2):e25449. PubMed ID: 32011104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing issues in elderly individuals living with HIV.
    Marzolini C; Livio F
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):643-659. PubMed ID: 31155978
    [No Abstract]   [Full Text] [Related]  

  • 12. Morbidity in older HIV-infected patients: impact of long-term antiretroviral use.
    Guaraldi G; Prakash M; Moecklinghoff C; Stellbrink HJ
    AIDS Rev; 2014; 16(2):75-89. PubMed ID: 24759453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing antiretroviral therapy in the elderly HIV patient.
    Guaraldi G; Pintassilgo I; Milic J; Mussini C
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1171-1181. PubMed ID: 30444968
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of concomitant medications in older HIV+ patients and comparison with general population.
    Gimeno-Gracia M; Crusells-Canales MJ; Javier Armesto-Gómez F; Rabanaque-Hernández MJ
    HIV Clin Trials; 2015; 16(3):117-24. PubMed ID: 25978302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
    Moore HN; Mao L; Oramasionwu CU
    AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of drug-drug interactions and impact on the effectiveness of antiretroviral therapy among patients living with HIV followed at an Infectious Diseases Referral Center in Belo Horizonte, Brazil.
    Pontelo BM; Greco DB; Guimarães NS; Rotsen N; Braga VAR; Pimentel PHN; Barbosa H; Barroso TM; Tupinambás U
    Braz J Infect Dis; 2020; 24(2):104-109. PubMed ID: 32360120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population.
    Gimeno-Gracia M; Crusells-Canales MJ; Armesto-Gómez FJ; Compaired-Turlán V; Rabanaque-Hernández MJ
    Clin Interv Aging; 2016; 11():1149-57. PubMed ID: 27616883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of non-antiretroviral drugs among individuals with and without HIV-infection: a Danish nationwide study.
    Rasmussen LD; Kronborg G; Larsen CS; Pedersen C; Gerstoft J; Obel N; Pottegård A
    Infect Dis (Lond); 2017 Jan; 49(1):42-54. PubMed ID: 27686116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study.
    Altunal LN; Yagcı Caglayık D; Ozel AS; Tukenmez Tigen E; Sili U; Erturk Sengel B; Aydın M; Korten V
    AIDS Patient Care STDS; 2023 Mar; 37(3):138-145. PubMed ID: 36812461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population.
    Nachega JB; Hsu AJ; Uthman OA; Spinewine A; Pham PA
    AIDS; 2012 Jul; 26 Suppl 1():S39-53. PubMed ID: 22781176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.